IDiyas

For the Inventor, By the Inventor

Carmel, IN, United States of America

Qing Shi

USPTO Granted Patents = 17

 

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:

goldMedal13 out of 4,442 
 
Eli Lilly and Company
 patents
silverMedal1 out of 202 
 
Elan Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 35 
 
Athena Neurosciences, Inc.
 patents
4. 4 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2003-2022

Loading Chart...
Loading Chart...
17 patents (USPTO):
1. 11453673 - Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors (2022-09-27),
2. 11401274 - [1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes (2022-08-02),
3. 11180503 - [1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivatives (2021-11-23),
4. 10138244 - Triazolopyrazinone derivative useful as a human PDE1 inhibitor (2018-11-27),
5. 9637495 - CGRP receptor antagonists (2017-05-02),
6. 8299061 - Inhibitors of diacylglycerol acyltransferase (2012-10-30),
7. 8133907 - Pyridine derivatives as dipeptedyl peptidase inhibitors (2012-03-13),
8. 8106090 - 1-amino linked compounds (2012-01-31),
9. 8076514 - Phenyl compounds and their use in the treatment of Type II diabetes (2011-12-13),
10. 7291619 - Melanocortin receptor agonists (2007-11-06),
11. 7186715 - Piperazine- and piperidine-derivatives as melanocortin receptor agonists (2007-03-06),
12. 6906056 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-06-14),
13. 6838455 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds (2005-01-04),
14. 6696438 - Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2004-02-24),
15. 6569851 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-05-27),

Title: Innovations and Achievements of Inventor Qing Shi

Introduction: Qing Shi is a prolific inventor based in Carmel, IN, known for his significant contributions to the field of pharmacology through his innovative compounds. With a remarkable portfolio comprising 17 patents, he has established himself as a key figure in the development of phosphodiesterase inhibitors aimed at treating various medical conditions.

Latest Patents: Among his notable patents, Qing Shi has developed substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors. This invention details a compound of Formula I, with R comprising methyl, ethyl, or cyclopropyl, and aims to serve as a PDE1 inhibitor. Another significant patent includes [1,2,4]triazolo derivatives as PDE1 inhibitors for the treatment of diabetes, featuring a compound where X options include CHCH, CHCHCH, OCH, or CHO, with R having potential variations such as ethyl, n-propyl, and more, meant to inhibit human PDE.

Career Highlights: Over the years, Qing Shi has made substantial strides in the industry while working at renowned companies like Eli Lilly and Company. His expertise and innovative thinking have allowed him to contribute to numerous advancements in pharmaceutical formulations.

Collaborations: Throughout his career, Qing has collaborated with esteemed colleagues such as James E. Audia and Warren Jaye Porter. These partnerships have enriched his work and fostered the exchange of innovative ideas within the realm of drug development.

Conclusion: In summary, Qing Shi's dedication and inventive spirit have resulted in a significant impact in pharmacology. His numerous patents highlight his innovative approaches to developing treatment options, positioning him as a valuable inventor in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…